A detailed history of Lpl Financial LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 11,503 shares of BBIO stock, worth $763,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,503
Previous 5,047 127.92%
Holding current value
$763,684
Previous $217,000 175.12%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$42.78 - $54.29 $276,187 - $350,496
6,456 Added 127.92%
11,503 $597,000
Q2 2025

Aug 12, 2025

BUY
$30.14 - $45.12 $152,116 - $227,720
5,047 New
5,047 $217,000
Q2 2022

Aug 12, 2022

SELL
$5.21 - $12.14 $28,477 - $66,357
-5,466 Reduced 33.54%
10,832 $98,000
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $119,627 - $279,673
16,298 New
16,298 $165,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $9.84B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.